Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The majority of 22 Dutch high-risk breast cancer families are due to either BRCA1 or BRCA2.
Eur J Hum Genet. 1996;4(4):225-30. doi: 10.1159/000472203.
Eur J Hum Genet. 1996.
PMID: 8875189
A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families.
Peelen T, van Vliet M, Petrij-Bosch A, Mieremet R, Szabo C, van den Ouweland AM, Hogervorst F, Brohet R, Ligtenberg MJ, Teugels E, van der Luijt R, van der Hout AH, Gille JJ, Pals G, Jedema I, Olmer R, van Leeuwen I, Newman B, Plandsoen M, van der Est M, Brink G, Hageman S, Arts PJ, Bakker MM, Devilee P, et al.
Peelen T, et al. Among authors: petrij bosch a.
Am J Hum Genet. 1997 May;60(5):1041-9.
Am J Hum Genet. 1997.
PMID: 9150151
Free PMC article.
Item in Clipboard
BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients.
Petrij-Bosch A, Peelen T, van Vliet M, van Eijk R, Olmer R, Drüsedau M, Hogervorst FB, Hageman S, Arts PJ, Ligtenberg MJ, Meijers-Heijboer H, Klijn JG, Vasen HF, Cornelisse CJ, van 't Veer LJ, Bakker E, van Ommen GJ, Devilee P.
Petrij-Bosch A, et al.
Nat Genet. 1997 Nov;17(3):341-5. doi: 10.1038/ng1197-341.
Nat Genet. 1997.
PMID: 9354803
Free article.
Item in Clipboard
Cite
Cite